• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚洲人群中ST段抬高型心肌梗死相关心源性休克的临床预测因素及预后

Clinical predictors and outcomes of ST-elevation myocardial infarction related cardiogenic shock in the Asian population.

作者信息

Djohan Andie Hartanto, Evangelista Lauren Kay Mance, Chan Koo-Hui, Lin Weiqin, Adinath Anand Ambhore, Kua Jie Li, Sim Hui Wen, Chan Mark Y, Ng Gavin, Cherian Robin, Wong Raymond C C, Lee Chi-Hang, Tan Huay-Cheem, Yeo Tiong-Cheng, Yip James, Low Adrian F, Sia Ching-Hui, Loh Poay Huan

机构信息

Department of Cardiology, National University Heart Centre Singapore, Singapore.

Division of Cardiology, Department of Medicine, Ng Teng Fong General Hospital, Singapore.

出版信息

Int J Cardiol Heart Vasc. 2024 Jul 12;53:101463. doi: 10.1016/j.ijcha.2024.101463. eCollection 2024 Aug.

DOI:10.1016/j.ijcha.2024.101463
PMID:39104850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11298930/
Abstract

BACKGROUND

Cardiogenic shock (CS) complicating myocardial infarction is associated with poor outcomes. Data among Asian populations are scarce. We aimed to investigate the long-term outcomes, prognostic factors, and predictors of CS among Asian ST elevation myocardial infarction (STEMI) patients.

METHODS

This was a retrospective cohort study of consecutive patients undergoing primary percutaneous coronary intervention (PPCI) for STEMI within our regional STEMI network between 2015 and 2019. The long-term outcomes of those with and without CS were compared. Clinical predictors of outcomes and development of CS were investigated.

RESULTS

A total of 1791 patients who underwent PPCI were included. Patients completed at least 2 years' follow-up with a median follow-up period of 2.6 years (IQR 1.0, 3,9). Overall, 208/1791 (11.6 %) STEMI patients developed CS. These patients were older (61.1 ± 12.5 vs 57.8 ± 12.2, P < 0.001) and mostly men (87.0 %). All-cause mortality (59.9 % vs 4.7 % P < 0.001), cardiac mortality (43.8 % vs 2.2 %, P < 0.001) and major adverse cardiovascular events (MACE) was significantly higher in the CS group (59.1 % vs 14.0 %, P < 0.001). Independent predictors of survival were higher index LVEF (adjusted hazards ratio [aHR] 0.967, 95 %CI 0.951-0.984, p < 0.001) and higher arterial pH at onset of shock (aHR 0.750, 0.626-0.897, p = 0.002). Increased serum lactate concentration independently predicts poor prognosis (aHR 1.084, 95 % CI 1.046-1.124, p < 0.001).

CONCLUSION

In Asian STEMI patients who underwent PPCI, CS was associated with poor outcomes. Higher LVEF on index admission was associated with better outcomes; while lactic acidosis independently predicted mortality.

摘要

背景

心肌梗死并发的心源性休克(CS)与不良预后相关。亚洲人群中的相关数据较少。我们旨在调查亚洲ST段抬高型心肌梗死(STEMI)患者中CS的长期预后、预后因素及预测因素。

方法

这是一项对2015年至2019年间在我们地区STEMI网络内行直接经皮冠状动脉介入治疗(PPCI)的连续患者进行的回顾性队列研究。比较了发生CS和未发生CS患者的长期预后。研究了预后及CS发生的临床预测因素。

结果

共纳入1791例行PPCI的患者。患者完成了至少2年的随访,中位随访期为2.6年(四分位间距1.0,3.9)。总体而言,1791例STEMI患者中有208例(11.6%)发生了CS。这些患者年龄更大(61.1±12.5岁对57.8±12.2岁,P<0.001),且大多为男性(87.0%)。CS组的全因死亡率(59.9%对4.7%,P<0.001)、心脏死亡率(43.8%对2.2%,P<0.001)和主要不良心血管事件(MACE)显著更高(59.1%对14.0%,P<0.001)。生存的独立预测因素为较高的入院时左室射血分数(LVEF)(调整后风险比[aHR]0.967,95%置信区间[CI]0.951 - 0.984,p<0.001)和休克发作时较高的动脉血pH值(aHR 0.750,0.626 - 0.897,p = 0.002)。血清乳酸浓度升高独立预测预后不良(aHR 1.084,95% CI 1.046 - 1.124,p<0.001)。

结论

在接受PPCI的亚洲STEMI患者中,CS与不良预后相关。入院时较高的LVEF与较好的预后相关;而乳酸酸中毒独立预测死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ae/11298930/8b21d160f242/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ae/11298930/481843f0d1ad/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ae/11298930/ed3e26387b7c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ae/11298930/61dc7b63d0c8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ae/11298930/8b21d160f242/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ae/11298930/481843f0d1ad/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ae/11298930/ed3e26387b7c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ae/11298930/61dc7b63d0c8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ae/11298930/8b21d160f242/gr4.jpg

相似文献

1
Clinical predictors and outcomes of ST-elevation myocardial infarction related cardiogenic shock in the Asian population.亚洲人群中ST段抬高型心肌梗死相关心源性休克的临床预测因素及预后
Int J Cardiol Heart Vasc. 2024 Jul 12;53:101463. doi: 10.1016/j.ijcha.2024.101463. eCollection 2024 Aug.
2
Comparison of the prognosis for different onset stage of cardiogenic shock secondary to ST-segment elevation myocardial infarction.比较不同发病阶段的 ST 段抬高型心肌梗死所致心原性休克的预后。
BMC Cardiovasc Disord. 2020 Jun 19;20(1):302. doi: 10.1186/s12872-020-01583-1.
3
Incidence and Predictors of Adverse Events Among Initially Stable ST-Elevation Myocardial Infarction Patients Following Primary Percutaneous Coronary Intervention.ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后稳定初期不良事件的发生率及预测因素。
J Am Heart Assoc. 2022 Sep 6;11(17):e025572. doi: 10.1161/JAHA.122.025572. Epub 2022 Sep 3.
4
The Impact of Sex on Cardiogenic Shock Outcomes Following ST Elevation Myocardial Infarction.性别对ST段抬高型心肌梗死所致心源性休克结局的影响。
J Clin Med. 2023 Sep 28;12(19):6259. doi: 10.3390/jcm12196259.
5
Outcomes following primary percutaneous coronary intervention for unprotected left main-related ST-segment elevation myocardial infarction.非保护左主干相关ST段抬高型心肌梗死的直接经皮冠状动脉介入治疗后的结果
J Cardiovasc Med (Hagerstown). 2015 Mar;16(3):163-9. doi: 10.2459/JCM.0000000000000075.
6
Efficacy of Mechanical Circulatory Support Used Before Versus After Primary Percutaneous Coronary Intervention in Patients with Cardiogenic Shock From ST-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis.机械循环支持在 ST 段抬高型心肌梗死所致心原性休克患者直接经皮冠状动脉介入治疗前后应用的疗效:系统评价和荟萃分析。
Cardiovasc Revasc Med. 2022 Sep;42:74-83. doi: 10.1016/j.carrev.2022.05.002. Epub 2022 May 6.
7
Electrocardiographic patterns and clinical outcomes of acute coronary syndrome cardiogenic shock in patients undergoing percutaneous coronary intervention - A propensity score analysis.经皮冠状动脉介入治疗中急性冠状动脉综合征心原性休克患者的心电图模式和临床结局 - 倾向评分分析。
Cardiovasc Revasc Med. 2024 Aug;65:58-64. doi: 10.1016/j.carrev.2024.02.022. Epub 2024 Mar 4.
8
Outcomes of patients with myocardial infarction and cardiogenic shock treated with culprit vessel-only versus multivessel primary PCI.仅罪犯血管血运重建与多血管血运重建治疗心肌梗死合并心原性休克患者的结局比较。
Hellenic J Cardiol. 2024 Mar-Apr;76:1-10. doi: 10.1016/j.hjc.2023.08.009. Epub 2023 Aug 24.
9
Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients.ST 段抬高型心肌梗死患者心源牲休克和死亡的危险因素。
Eur Heart J Acute Cardiovasc Care. 2018 Feb;7(1):7-15. doi: 10.1177/2048872617706503. Epub 2017 Apr 28.
10
Cardiogenic Shock Prior to Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction: Outcomes and Predictors of Mortality (ANZACS-QI 73).ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗前心原性休克:死亡率的结局和预测因素(ANZACS-QI 73)。
Heart Lung Circ. 2024 Apr;33(4):450-459. doi: 10.1016/j.hlc.2024.01.009. Epub 2024 Mar 7.

本文引用的文献

1
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
J Am Coll Cardiol. 2022 May 3;79(17):e263-e421. doi: 10.1016/j.jacc.2021.12.012. Epub 2022 Apr 1.
2
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
3
Long-Term Clinical Impact of Cardiogenic Shock and Heart Failure on Admission for Acute Myocardial Infarction.
急性心肌梗死后因心原性休克和心力衰竭入院的长期临床影响。
Int Heart J. 2021 May 29;62(3):520-527. doi: 10.1536/ihj.20-646. Epub 2021 May 15.
4
Characteristics and outcomes of young patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: retrospective analysis in a multiethnic Asian population.在多民族亚洲人群中进行的经皮冠状动脉介入治疗的年轻 ST 段抬高型心肌梗死患者的特征和结局:回顾性分析。
Open Heart. 2021 Jan;8(1). doi: 10.1136/openhrt-2020-001437.
5
Impact of the COVID-19 Pandemic on Door-to-Balloon Time for Primary Percutaneous Coronary Intervention - Results From the Singapore Western STEMI Network.COVID-19 大流行对直接经皮冠状动脉介入治疗的门球时间的影响 - 来自新加坡西部 STEMI 网络的结果。
Circ J. 2021 Jan 25;85(2):139-149. doi: 10.1253/circj.CJ-20-0800. Epub 2020 Nov 7.
6
Fourth universal definition of myocardial infarction (2018).心肌梗死的第四次全球定义(2018年)。
Eur Heart J. 2019 Jan 14;40(3):237-269. doi: 10.1093/eurheartj/ehy462.
7
Evolving Concepts in Diagnosis and Management of Cardiogenic Shock.心源性休克的诊断和治疗观念的演变。
Am J Cardiol. 2018 Sep 15;122(6):1104-1110. doi: 10.1016/j.amjcard.2018.05.040. Epub 2018 Jun 22.
8
Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative.急性心肌梗死合并心源性休克早期机械循环支持的可行性:底特律心源性休克倡议
Catheter Cardiovasc Interv. 2018 Feb 15;91(3):454-461. doi: 10.1002/ccd.27427. Epub 2017 Dec 20.
9
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association.当代心源性休克管理:美国心脏协会的科学声明
Circulation. 2017 Oct 17;136(16):e232-e268. doi: 10.1161/CIR.0000000000000525. Epub 2017 Sep 18.
10
Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock.早期启动机械循环支持对心源性休克患者生存率的影响。
Am J Cardiol. 2017 Mar 15;119(6):845-851. doi: 10.1016/j.amjcard.2016.11.037. Epub 2016 Dec 18.